X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Diabetes Care DrugsCompanies (2024 - 2029)

Numerous companies in the pharmaceutical sector are making significant strides in the industry. These firms, which range from those specializing in biotechnology to those focused on the production of generic drugs, are working tirelessly to develop, manufacture, and market various medical products. They are also committed to conducting extensive research and development to introduce innovative solutions to address various health challenges. These corporations, despite operating in a highly competitive environment, continue to uphold high standards of quality and safety in their operations.

Top Companies in Diabetes Care Drugs Market

This report lists the top Diabetes Care Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Diabetes Care Drugs industry.

  1. Novo Nordisk

  2. Sanofi

  3. AstraZeneca

  4. Boehringer Ingelheim

  5. Eli Lilly and Company

*Disclaimer: Top companies sorted in no particular order

Diabetes Care Drugs Market Major Players

Diabetes Care DrugsMarket Concentration

Diabetes Care Drugs Market Concentration

Diabetes Care DrugsCompany List

  • Novo Nordisk

  • Sanofi

  • Eli Lilly and Company

  • Biocon

  • AstraZeneca

  • Bristol Myers Squibb

  • Boehringer Ingelheim

  • Mylan

  • Pfizer

  • Johnson & Johnson

  • Merck & Co.

  • Novartis

  • Astellas Pharma

  • Teva Pharmaceuticals


Specific to Diabetes Care Drugs Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Diabetes Care Drugs Market Companies Summary

The diabetes care drugs market saw significant changes due to the COVID-19 pandemic, highlighting the potential for advancements in diabetes care. These advancements include virtual consultations between healthcare professionals and individuals with diabetes and the use of diabetes technology. The crisis led to increased interest in remote care, removal of regulatory barriers, and the use of personal blood glucose meters and continuous glucose monitoring devices in hospitals. The high prevalence of diabetes among individuals hospitalized with COVID-19 emphasized the significance of diabetes care devices. The market is moderately fragmented, with a few significant and generic players dominating. The insulin drugs and Sglt-2 drugs market are dominated by a few major players, while the market for oral drugs comprises more generic players. The intensity of competition among the players is high, with each player striving to develop new drugs and offer them at competitive pricing. To increase their market shares, players are tapping into new markets, especially emerging economies where the demand is very high compared to the supply.

Explore More

Diabetes Care Drugs Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Novo Nordisk

      2. 1.1.2 Sanofi

      3. 1.1.3 Eli Lilly and Company

      4. 1.1.4 Biocon

      5. 1.1.5 AstraZeneca

      6. 1.1.6 Bristol Myers Squibb

      7. 1.1.7 Boehringer Ingelheim

      8. 1.1.8 Mylan

      9. 1.1.9 Pfizer

      10. 1.1.10 Johnson & Johnson

      11. 1.1.11 Merck & Co.

      12. 1.1.12 Novartis

      13. 1.1.13 Astellas Pharma

      14. 1.1.14 Teva Pharmaceuticals

    2. *List Not Exhaustive
    3. 1.2 Company Share Analysis

      1. 1.2.1 Insulin Drugs

        1. 1.2.1.1 Novo Nordisk

        2. 1.2.1.2 Sanofi

        3. 1.2.1.3 Eli Lilly and Company

        4. 1.2.1.4 Others

Diabetes Care Drugs Companies FAQs

Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim and Eli Lilly and Company are the major companies operating in the Diabetes Care Drugs Market.

Diabetes Drug Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)